IMPACT OF INHIBITION OF PCSK-9 AMONG RENAL TRANSPLANT RECIPIENTS WITH HIGH CARDIOVASCULAR RISK

被引：0
|
作者：
Alotaibi, Torki [1 ]
Gheith, Osama Ashry Ahmed [1 ,2 ]
Nagib, Ayman Maher [1 ,2 ]
Aboatya, Hasaneen Hasaneen Ahmed Aboatya [1 ]
Halim, Medhat M. A. [1 ]
Mahmoud, Tarek S. H. [1 ]
Emam, Mohamed [1 ]
Mostafa, Mohamed [1 ]
Elsayed, Zakaria [1 ]
Nair, Prasad [1 ]
机构：
[1] OTC Kuwait, Kuwait, Kuwait
[2] Mansoura Univ, Nephrol, Mansoura, Egypt
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO972
引用
收藏
页码：I706 / I706
页数：1
相关论文
共 50 条
  • [41] Atherosclerosis PCSK9 inhibition reduces cardiovascular events in high-risk patients
    Huynh, Karina
    NATURE REVIEWS CARDIOLOGY, 2017, 14 (05) : 2 - 2
  • [42] Effect of PCSK9 inhibition with alirocumab on lipoprotein(a) in patients with high risk of cardiovascular disease
    Safdar, S.
    Cramb, R.
    Dawson, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2017, 28 : E12 - E12
  • [43] PCSK9 Inhibition to Reduce Cardiovascular Risk Tempering Expectations
    Waters, David D.
    Hsue, Priscilla Y.
    CIRCULATION RESEARCH, 2017, 120 (10) : 1537 - 1539
  • [44] Inclisiran-Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
    Wolowiec, Lukasz
    Osiak, Joanna
    Wolowiec, Anna
    Wijata, Aleksandra
    Grzesk, Elzbieta
    Kozakiewicz, Mariusz
    Banach, Joanna
    Nowaczyk, Alicja
    Nowaczyk, Jacek
    Grzesk, Grzegorz
    PHARMACEUTICS, 2023, 15 (02)
  • [45] Patient and Graft Outcome among High Immunologic Risk Renal Transplant Recipients
    Mora, Jeffrey
    Cabanayan-Casasola, Concesa B.
    Padua, Florecita R.
    Mendoza, Myrna T.
    TRANSPLANTATION, 2018, 102 : S485 - S486
  • [46] Patient and Graft Outcome Among High Immunologic Risk Renal Transplant Recipients
    Mora, Jeffrey
    Cabanayan-Casasola, Concesa B.
    Padua, Florecita R.
    Mendoza, Myrna T.
    TRANSPLANTATION, 2018, 102 : S90 - S91
  • [47] Risk of fracture among dialysis and renal transplant recipients
    Roe, Simon
    Porter, Christine
    Tata, Laila
    Hubbard, Richard
    Cassidy, Michael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 361 - 361
  • [48] Risk and outcome of pyelonephritis among renal transplant recipients
    Graversen, Mette Elneff
    Dalgaard, Lars Skov
    Jensen-Fangel, Soren
    Jespersen, Bente
    Ostergaard, Lars
    Sogaard, Ole Schmeltz
    BMC INFECTIOUS DISEASES, 2016, 16
  • [49] Risk and outcome of pyelonephritis among renal transplant recipients
    Mette Elneff Graversen
    Lars Skov Dalgaard
    Søren Jensen-Fangel
    Bente Jespersen
    Lars Østergaard
    Ole Schmeltz Søgaard
    BMC Infectious Diseases, 16
  • [50] Hyperuricemia as a Cardiovascular Risk Factor in Renal Transplant Recipients.
    Uyar, M. Erkmen
    Sezer, S.
    Bal, Z.
    Guliyev, O.
    Colak, T.
    Demirci, B. Gurlek
    Haberal, M.
    TRANSPLANTATION, 2014, 98 : 521 - 521
12345